Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.

Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW.

Rheumatol Int. 2004 Mar;24(2):63-70. Epub 2003 Sep 25.

PMID:
14513268
[PubMed - indexed for MEDLINE]
2.

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

Ringe JD, Faber H, Fahramand P, Schacht E.

J Rheumatol Suppl. 2005 Sep;76:33-40.

PMID:
16142849
[PubMed - indexed for MEDLINE]
3.

Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium.

Ringe JD, Cöster A, Meng T, Schacht E, Umbach R.

Calcif Tissue Int. 1999 Oct;65(4):337-40.

PMID:
10485988
[PubMed - indexed for MEDLINE]
5.

[Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].

Ringe JD, Cöster A, Meng T, Schacht E, Umbach R.

Z Rheumatol. 2000 Jun;59(3):176-82. German.

PMID:
10929446
[PubMed - indexed for MEDLINE]
6.

Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.

Reginster JY, Lecart MP, Richy F.

J Rheumatol Suppl. 2005 Sep;76:21-5.

PMID:
16142847
[PubMed - indexed for MEDLINE]
7.

Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients.

Ringe JD, Farahmand P, Schacht E.

Rheumatol Int. 2013 Mar;33(3):637-43. doi: 10.1007/s00296-012-2429-x. Epub 2012 Apr 8.

PMID:
22527138
[PubMed - indexed for MEDLINE]
8.

Potential of alfacalcidol for reducing increased risk of falls and fractures.

Ringe JD, Schacht E.

Rheumatol Int. 2009 Aug;29(10):1177-85. doi: 10.1007/s00296-008-0835-x. Epub 2009 Jan 22.

PMID:
19159932
[PubMed - indexed for MEDLINE]
9.

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.

Ringe JD, Farahmand P, Faber H, Dorst A.

Rheumatol Int. 2009 Jan;29(3):311-5. doi: 10.1007/s00296-008-0689-2. Epub 2008 Sep 2.

PMID:
18762944
[PubMed - indexed for MEDLINE]
10.

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.

Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.

Calcif Tissue Int. 2005 Mar;76(3):176-86. Epub 2005 Feb 7.

PMID:
15692726
[PubMed - indexed for MEDLINE]
11.

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.

Ringe JD, Dorst A, Faber H, Ibach K, Sorenson F.

Osteoporos Int. 2003 Oct;14(10):801-7. Epub 2003 Aug 28.

PMID:
14610641
[PubMed - indexed for MEDLINE]
12.

[Prevention of glucocorticoid-induced osteoporosis in patients with primary glomerulonephritis].

Chen H, Wang M.

Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2207-10. Chinese.

PMID:
16321186
[PubMed - indexed for MEDLINE]
13.

Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.

Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.

Epilepsia. 2013 Nov;54(11):1997-2004. doi: 10.1111/epi.12351. Epub 2013 Sep 6.

PMID:
24010637
[PubMed - indexed for MEDLINE]
14.

Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.

Levis S, Theodore G.

J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13.

PMID:
22716221
[PubMed - indexed for MEDLINE]
Free Article
15.

Lack of generalizable evidence of the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis: comment on the article by Ringe et al.

Barthel HR, Vieth R.

Rheumatol Int. 2004 Jul;24(4):250-1. Epub 2004 Feb 10. No abstract available.

PMID:
14770266
[PubMed - indexed for MEDLINE]
16.

Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.

Nuti R, Bianchi G, Brandi ML, Caudarella R, D'Erasmo E, Fiore C, Isaia GC, Luisetto G, Muratore M, Oriente P, Ortolani S.

Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10.

PMID:
16283320
[PubMed - indexed for MEDLINE]
17.

Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.

PMID:
15647969
[PubMed - indexed for MEDLINE]
18.

Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study.

Ringe JD, Dorst A, Faber H, Ibach K.

Rheumatol Int. 2004 Mar;24(2):110-3. Epub 2003 Sep 10.

PMID:
13680141
[PubMed - indexed for MEDLINE]
19.

Prevention of corticosteroid-induced osteoporosis by alfacalcidol.

Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, Foldes J, Speer G, Bossanyi A.

Z Rheumatol. 2000;59 Suppl 1:48-52.

PMID:
10769437
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk